Chemerin is also a determinant of endothelial dysfunction, with high titers negatively correlated with flow-mediated dilatation (odds ratio of 1.58) and arterial stiffness (odds ratio of 3.75) in hypertensive patients [47]. Here, RARRES2 is linked to endothelial dysfunction.